Northcape Capital Pty Ltd Purchases 282 Shares of Colgate-Palmolive (NYSE:CL)

Northcape Capital Pty Ltd raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,012 shares of the company’s stock after buying an additional 282 shares during the period. Colgate-Palmolive comprises approximately 0.1% of Northcape Capital Pty Ltd’s investment portfolio, making the stock its 28th biggest position. Northcape Capital Pty Ltd’s holdings in Colgate-Palmolive were worth $547,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the third quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new position in Colgate-Palmolive during the 3rd quarter worth $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $64,000. True Wealth Design LLC lifted its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its position in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on CL. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday. Finally, TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $104.16.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $87.31 on Wednesday. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market cap of $71.33 billion, a PE ratio of 25.02, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The company’s 50 day moving average is $93.03 and its 200 day moving average is $98.31.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.